San Francisco, California, United States In 2014 was created Open Philanthropy Project, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the San Francisco. The company was established in North America in United States.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Open Philanthropy Project, startups are often financed by Temasek Holdings, Sailing Capital, Raj Luhar. The meaningful sponsors for the fund in investment in the same round are William Adams, Viking Global Investors, UBS. In the next rounds fund is usually obtained by Vikrant Bhargava, Shakil Khan, Sebastian Pollok.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Social Entrepreneurship, Nutrition. Among the most popular portfolio startups of the fund, we may highlight Impossible Foods.
The fund is constantly included in less than 2 investment rounds annually. When the investment is from Open Philanthropy Project the average startup value is more than 1 billion dollars. Speaking about the real fund results, this Corporate Investor is 40 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2019. Deals in the range of 50 - 100 millions dollars are the general things for fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AFSquare | California, Culver City, United States |
| Berninger Verwaltungs GmbH | Bayern, Germany, Gräfelfing |
| Broken Arrow Venture Capital | California, Los Altos, United States |
| Falls Angel Fund | - |
| Gerako | Espoo, Finland, Uusimaa |
| Global Financial Services Opportunity Fund | - |
| Kenda Capital | Rijswijk, The Netherlands, Zuid-Holland |
| Matmut | France, Haute-Normandie, Rouen |
| Ningbo Guangmu Touzi | China, Ningbo, Zhejiang |
| Nippon Kouatsu Electric Co | Aichi Prefecture, Japan, Obu |
| Pi Capital | England, London, United Kingdom |
| Shenzhen Aoto Electronics | China, Guangdong, Tianjin |
| Startup Education | - |
| Topspin Fund | - |
| VARECO HOLDINGS | - |
| Weien Touzi | China, Japan, Kagoshima Prefecture |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Piezo Therapeutics | $2M | 19 Jan 2023 | Atlanta, Georgia, United States | ||
Icosavax | $100M | 07 Apr 2021 | Seattle, Washington, United States | ||
Sherlock Biosciences | $31M | 23 Apr 2019 | Cambridge, Massachusetts, United States |
– Icosavax closed a $100m Series B Financing, led by RA Capital Management and joined by Janus Henderson Investors, Perceptive Advisors, Viking Global Investors, Cormorant Asset Management, Omega Funds, and Surveyor Capital (a Citadel company).
– A previously announced funding from Open Philanthropy was included in this round.
– The proceeds of the financing will support the development of Icosavax’s bivalent respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) vaccine program through initial clinical studies, continued evaluation of its SARS-CoV-2 vaccine candidate, and further expansion of the company’s pipeline of VLP vaccine candidates focused on protecting older adults from life-threatening respiratory diseases.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Piezo Therapeutics | $2M | 19 Jan 2023 | Atlanta, Georgia, United States | ||
Icosavax | $100M | 07 Apr 2021 | Seattle, Washington, United States | ||
Sherlock Biosciences | $31M | 23 Apr 2019 | Cambridge, Massachusetts, United States |
